Hspc (Hspc)
Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 68001-345
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 68001-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Mpeg (Mpeg)
Peglyated (Peglyated)
Graph (Graph)
Doxorubicin HCl Liposome Inj 20mg_10ml Label (Image 01)
This is a product information label for a Doxorubicin Hydrochloride Liposome Injection medication manufactured by Natco Pharma Ltd for BluePoint Laboratories. The drug is a cytotoxic agent used for intravenous infusion only and must be diluted. The label provides dosage information and notes that the unused portion of the single-dose vial should be discarded. The medication must be refrigerated and cannot be frozen. The label also includes lot and expiration information, a caution to retain the vial in the carton until use, and a sterile marker.*
Doxorubicin HCl 20mg/10ml Carton Rev 1219 (Image 02)
Doxorubicin HCl Liposome Inj 50mg_25ml Label (Image 03)
This is a description of a cytotoxic agent, DOXOrubicin e Hydrochloride, in liposome injection form. It comes in a 50mg/25mL (2 mg/mL) dosage and is for intravenous infusion only. You must refrigerate it at 2°C-8°C but avoid freezing it. It includes a caution not to print on the package and a reminder to retain the vial in its carton until use. The drug is sterilized and manufactured by Natco Pharma Ltd in India for BluePoint Laboratories. The package size is 85x45 mm, and it is a single-dose vial. Any unused portions must be discarded.*
Doxorubicin HCl 50mg/25ml Carton Rev 1219 (Image 04)
This appears to be a description of a medication used for intravenous infusion. The medication is a liposomal formulation of DOXOrubicin Hydrochloride, a cytotoxic agent used for the treatment of cancer. It is provided in a single-dose vial, and any unused portion should be discarded. The usual dosage information can be found in the package insert. The medication should be diluted prior to administration, and refrigerated between 2-6 degrees Celsius until use.*
Stru (Stru)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
